Our group used PI-103 to study the role of the PI3K pathway in B-CLL adhesion to stromal cells, previously shown to provide efficient B-CLL protection (Kurtova et al., 2009). Here, PIK3CD is linked to B-cell chronic lymphocytic leukemia.